Medically Home Group, Inc., a Boston, MA-based technology-enabled services company has raised $10 million in Series B funding led by Cardinal Health and other investors. This strategic investment for Medically Home from Cardinal Health and other investors illustrates the rapid movement in the market for innovative value-based models. The company plans to use the latest round of funding to support scaling efforts and to realize a common vision of enabling cost-effective, patient-centric
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
Adventist Integrates CancerIQ Platform with Cerner EHR Systemwide to Get AHEAD of Cancer
Adventist Health is getting AHEAD of hereditary cancer (which tends to be earlier onset, more aggressive, and accounts for 10 percent of all new diagnoses). The Adventist Health Early All-Around Detection – or AHEAD Program – at Adventist Health is a population hereditary cancer risk assessment initiative.To ensure patients in both urban and rural settings have access to the preventive services needed to reduce risk, Adventist Health is partnering with CancerIQ to identify candidates for genetic
Read More
Consumer Awareness of Personalized Medicine Has Only Grown by 1% YoY Since 2013
Consumer awareness of personalized medicine is up 4% from 2018, according to a new report from Dosis, an AI-powered personalized dosing platform. The 2019 Dosis Personalized and Digital Medicine Consumer Report surveyed more than 1,000 consumers, weighted for the U.S. population, to gain a better understanding of how big the disconnect is between the advances in personalized medicine approaches and general consumer awareness of its benefits.Consumer Awareness of Personalized Medicine Continues
Read More
RefleXion Medical Receives $60M Loan for Biology Guiding Radiotherapy Machine
RefleXion Medical, Inc., a biotargeting oncology company developing the first and only biology-guided radiotherapy (BgRT) machine* for targeted cancer treatment has received a $60M senior secured term loan from Oxford Finance LLC. The company plans to use the loan to support the completion of the FDA clearance process for its biology-guided BgRT system and its subsequent commercial launch.
Building from Positron
Emission Tomography
Positron emission tomography (PET) is an established
Read More
Amgen, Syapse Partner to Develop Observational Research Analytics for Precision Oncology
Amgen, a world leader in biotechnology, and Syapse, a company powering precision medicine insights through its global provider network, today announced a precision medicine collaboration in oncology. Under the terms of the collaboration, Amgen and Syapse will develop observational research analytics to assess treatment outcomes for areas of unmet need in oncology.Generates Insights from Real-World Evidence for Potential Use in Regulatory FilingsThis effort will identify existing patients within
Read More
Pfizer & Concerto HealthAI Team Up on Precision Oncology Collaboration
Concerto HealthAI announced a deal
with Pfizer, through which Pfizer will
harness Concerto HealthAI’s eurekaHealth AI platform
and real-world data (RWD) to help identify new and more precise treatment
options as well as accelerate completion times for various outcomes studies. Concerto
HealthAI is comprised of the leading healthcare data scientists, health
economists, epidemiologists, and AI software engineers to advance flexible and
increasingly enterprise grade solutions for advancing RWE into
Read More
Deep Lens Lands $14M to Scale AI-Driven Digital Pathology Platform
Deep Lens, Inc., a Columbus, OH-based AI-driven digital pathology company focused on clinical trial recruitment at the time of diagnosis has raised $14 million in Series A funding. The Series A round was led by Northpond Ventures with participation from existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners. The funding comes months after Deep Lens emerged from stealth in October 2018 with a $3.2M seed round, which brings their funding to date total to $17.5
Read More
March 2019 News, Merger & Acquisition, IPO, Public Company Performance Summary
A brief summary of noteworthy news, health IT M&A activity, IPOs, and public company performance during the month of March.
Noteworthy News
Amazon, JP Morgan, Berkshire Names New Joint Venture Haven
Amazon, J.P. Morgan, and Berkshire Hathaway name joint venture Haven. In January 2018, the three founding companies announced plans to create this independent organization, now called Haven, which is free from profit-making incentives and constraints. Haven’s focus is the 1.2 million
Read More
Study: Telerehabilitation Could Improve Patients With Late-Stage Cancer
Telerehabilitation services to patients with late-stage cancer can improve their physical function, pain and quality of life while allowing them to spend less time in hospitals and nursing homes, according to recent research led by Andrea Cheville, M.D., a Mayo Clinic physical medicine and rehabilitation physician. The research team also included Timothy Moynihan, M.D.; and Charles Loprinzi, M.D. -- all from Mayo Clinic -- as well as Jeph Herrin, Ph.D., Yale School of Medicine, and Kurt Kroenke,
Read More
Why Walmart Centers of Excellence Model Could Redefine How Employers Deliver Quality Care
Mitigating the cost of healthcare expenses has long been an uphill battle for employers, though the problem has become particularly pressing in recent years. The price tags for routine treatments and specialty services alike are on the rise; patients and payers alike shoulder heavy cost burdens for everyday care needs. The benefits packages that may have provided sufficient coverage a decade ago are now stretching to cover costs -- and the companies paying out those benefits are desperately
Read More
